MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jconrel.2025.114274

Медицинская библиотека · Journal of controlled release : official journal of the Controlled Release Society · 2025

Glycoliposomes target lymphatic dendritic cells in a size-dependent manner to activate natural killer T cells against breast tumors.

Hong Taehun, Masuda Keita, Nakashima Yuki, Li Shangwei, Chen Pengwen, Hu Guanghao, Igarashi Kazunori, Kimura Ayumi, Fujita Koji, Umezu Tomohiro, Kuroda Masahiko, Cabral Horacio

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Glycolipids have high potential for activating natural killer T (NKT) cells to mediate robust antitumor responses. However, critical challenges, such as low baseline NKT cell counts and the risk of unintentionally engaging immunosuppressive NKT subsets that dampen immune activation, have limited their clinical efficacy. Because antitumor NKT cells are functionalized by dendritic cells (DCs) in lymph nodes, targeting these cells is the key to selective antitumor NKT activation. Here, we developed size-modulated glycoliposomes using the potent glycolipid RK-163 (RK) for selectively targeting lymphatic DCs and promoting strong antitumor efficacy. Our results showed that RK glycoliposomes (RK-lipo) with 100 nm diameter achieved superior lymph node accumulation and DC uptake, leading to high IFN-γ secretion, expansion of NKT cell populations in lymph nodes, and reduction of anti-inflammatory signals. Furthermore, we confirmed an increased level of NKT cells in tumors after treatment with 100 nm RK-lipo, enhancing antitumor immunity in a triple-negative breast cancer (TNBC) murine model. Thus, the 100 nm RK-lipo suppressed the growth of orthotopic breast tumors, significantly extending survival with reduced adverse effects. These findings support the potential of targeting DCs with glycoliposomes to promote NKT cell activation, which provides a promising strategy for effective anti-tumor immunotherapy.

Для цитирования: Hong Taehun, Masuda Keita, Nakashima Yuki, Li Shangwei, Chen Pengwen, Hu Guanghao, Igarashi Kazunori, Kimura Ayumi, Fujita Koji, Umezu Tomohiro, Kuroda Masahiko, Cabral Horacio. Glycoliposomes target lymphatic dendritic cells in a size-dependent manner to activate natural killer T cells against breast tumors.. Journal of controlled release : official journal of the Controlled Release Society. 2025. DOI: 10.1016/j.jconrel.2025.114274.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.